Recruiting Sarcoma Studies in Bethesda
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Background: The drug PEN-866 can remain in tumor cells longer than it does in normal cells. It also may be more effective than other drugs at treating Ewing sarcoma and rhabdomyosarcoma. Researchers ...
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial
This phase II trial tests whether atezolizumab in combination with selinexor works to shrink tumors in patients with alveolar soft part sarcoma and whether the study drugs are better than the usual ap...
About Sarcoma Clinical Trials in Bethesda
Sarcomas are rare cancers that arise in bone and soft tissues including muscle, fat, blood vessels, and connective tissue. There are more than 70 subtypes of sarcoma. Treatment usually involves surgery combined with radiation and/or chemotherapy.
There are currently 2 sarcoma clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 91 participants. Research is being sponsored by National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.
Sarcoma Clinical Trials in Bethesda — FAQ
Are there sarcoma clinical trials in Bethesda?
Yes, there are 2 sarcoma clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Bethesda?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.
Are clinical trials in Bethesda free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.
What sarcoma treatments are being tested?
The 2 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma.
Data updated March 2, 2026 from ClinicalTrials.gov